An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant

Signal Transduct Target Ther. 2022 Dec 14;7(1):390. doi: 10.1038/s41392-022-01246-x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphavirus*
  • COVID-19*
  • Humans
  • Replicon
  • SARS-CoV-2 / genetics
  • Spike Glycoprotein, Coronavirus / genetics

Substances

  • spike protein, SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Supplementary concepts

  • SARS-CoV-2 variants